@Filmoreorless

Really only On Here now for #Knicks and #NBA twitter

 Brighton, NY
Joined May 2013
  • Tweets2.6K
  • Following853
  • Followers1.3K
98Media
#CMS unveiled its Transition Coverage for Emerging Technologies proposal last week—the agency’s second go-around at trying to streamline #Medicare coverage of innovative new devices. Here’s our initial analysis of the plan, with 10 key takeaways. ➡️ tinyurl.com/3y5bsk6c
3
5
234
OIRA @OMBPress site seems to be down, or is it just me?
2
162
The European Medicines Agency (@EMA_News) will launch a year-long pilot next month to give 10 makers of innovative devices the opportunity to get early feedback from EU expert panels on clinical trial planning to facilitate the MDR assessment process. #regulatory
1
4
5
270
Interesting impact analysis from use of 510(k) predicates that underwent high risk (class I) recalls
Kushal Kadakia, MD@ktkadakia10 Jan 2023
Replying to @ktkadakia @US_FDA @JAMA_current @CesarCaraballoC @jsross119 @hmkyale @JAMAInternalMed
(9/15) Lastly, we matched recalled predicates to contemporaneously authorized recall-free controls, and compared recall rates among descendants. The risk of a Class I recall was increased *sixfold* for devices that used a recalled predicate.
3
349
During EU Council meeting just now: Health ministers unanimously spoke in support the European Commission's proposal to extend EU Medical Device Regulation transition: to 2027 for high-risk devices and 2028 for low-mid-risk devices. #Medicaldevices
1
2
5
The Commission plans to introduce legislation to make the extension happen early next year, according to EU Health Commissioner Stella Kyriakides. In the meantime, "bridging" measures for devices whose CE marks are expiring soon will be issued by the Commission in coming days
1
4
The only pushback to the EU Commission's plan during the Council briefing was from Malta, who preferred setting one new transition date - in 2028 - for all devices, rather than risk-based phases
4
Top @Medtronic execs recently met with FDA about AI-enabled products Also noteworthy: they apparently traveled to meet onsite at FDA headquarters, which is not so common nowadays
2
1
5
What Do the US Midterms Mean for #Medtech? @medicaldevices's Mark Leahey and @AdvaMedUpdate's Greg Crist offer their perspectives on this podcast with Market Pathways editors Stephen Levin (@StephenLevinMTS) and David Filmore (@MedtechDavid). ➡ bit.ly/3P03sJe
1
4
1
3
#Regulatory Doc of the Week: "Guiding Principles for Safety and Effectiveness Evaluation of Medical Devices Using Nanomaterials Part III: Biological Compatibility/Toxicological Evaluation (Draft)" View the document here (link in Simplified Chinese). ➡️cmde.org.cn/xwdt/zxyw/202211…
1
3
1
4
China’s National Medical Products Administration is consistently one of the most prolific #regulatory agencies in publishing guidance and other #medtech policy documents. NMPA issued 26 documents last month— mostly technical review guidelines—to the US FDA’s 14.
1
2
2
4
The dude in this story who vomited in a trash can after being told he had to cut hundreds from his team is my people nytimes.com/2022/11/11/techn…

Two Weeks of Chaos: Inside Elon Musk’s Takeover of Twitter (Published 2022)

Mr. Musk ordered immediate layoffs, fired executives by email and laid down product deadlines, transforming the company.

nytimes.com
Look out for our new Doc of the Week threads 👇 And subscribe to @Market_Pathways to access Document Depot - a continuously updated database of medtech regulatory, reimbursement, policy documents from US, Europe, Asia and elsewhere > bit.ly/3nlJpY6
Market Pathways | MedTech Regulatory & Policy@Market_Pathways1 Nov 2022
#Regulatory Doc of the Week: “Developing and Responding to Deficiencies in Accordance with the Least Burdensome Provisions: Guidance for Industry and #FDA Staff” @US_FDA, October 26, 2022 Here are 3 reasons why this matters. 🧵⬇️
1
4
CMS coverage office hasn't had a lot of staff turnover, according to CAG director Tamara Syrek Jensen. "I hope I'm not jinxing myself," she says. @MedTechCon #medtechcon
2
5
CMS Tamara Syrek Jensen: On the day the (repealed) Medicare Coverage of Innovative Technology (MCIT) was set to take effect last year, "it was not going to work." CMS didn't have tools in place to implement it, she says at @MedTechCon panel this morning #medtechcon #Medicare
3
1
4
Join our Editor-in-Chief @DCassak at #MedTechCon presented by @AdvaMedUpdate, Monday, October 24 from 4:30 PM to 5:00 PM in the panel session, "Care of the Future: Smarter, Less Invasive, More Personalized." Learn more here. ➡️ themedtechconference.com/202…
1
4
3
5
We’re ready and excited for #MedTechCon in beautiful Boston presented by @AdvaMedUpdate. Check us out at Booth 213 and come meet our team. 👋
3
3
5
In this month’s spotlight from Pathways’ Document Depot, Malaysia and the Philippines roll out policy docs that build on the decade-long project to harmonize device regulations in Southeast Asia. ➡️ bit.ly/3eMjsR9 #regulatory #medtech
5
5
NEW #PODCAST EPISODE: "What in the (Medtech) World is Happening?" Market Pathways’ editors @StephenLevinMTS and @MedtechDavid talk about global #medtech policy issues they’ll be paying attention to this fall. Listen here. ➡️ bit.ly/3f4VjlR Expand to learn more. ⬇️
1
4
4
Load more